DeepMed Research

IPSEN, OOO

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 1929-01-01

Employees: 5.7K

Market Cap: $9.8B

Website: https://www.ipsen.com/

Clinical Trials

Dysport® Adult Upper Limb Spasticity Extension Study

Phase 3

Completed

Conditions: Nervous System Disorders

Interventions: Biological: Botulinum toxin type A

First Posted Date: 2011-03-11

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 258

Registration Number: NCT01313312

Locations: 🇵🇱
Malopolskie Centrum Medyczne, Krakow, Poland
🇷🇺
State University, St Petersburg, Russian Federation
🇸🇰
Derer's Hospital, Bratislava, Slovakia

and more 31 locations

Dysport® Adult Upper Limb Spasticity

Phase 3

Completed

Conditions: Nervous System Disorders

Interventions: Drug: Placebo
Biological: Botulinum toxin type A

First Posted Date: 2011-03-11

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 243

Registration Number: NCT01313299

Locations: 🇭🇺
Petz Aladar County Hospital, Gyor, Hungary
🇷🇺
Medical Rehabilitation Center, Moscow, Russian Federation
🇸🇰
Univerzitna nemocnica Bratislava, Bratislava, Slovakia

and more 36 locations

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

Phase 3

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Non steroidal anti androgens and LHRH-a
Drug: Lanreotide, non steroidal anti androgens and LHRH-a

First Posted Date: 2011-03-11

Last Posted Date: 2019-11-22

Lead Sponsor: Ipsen

Target Recruit Count: 3

Registration Number: NCT01313273

Locations: 🇮🇹
A.O. S. Luigi Gonzaga, Orbassano ( TO), Italy

Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia

Phase 3

Completed

Conditions: Cervical Dystonia

Interventions: Biological: Botulinum toxin type A
Drug: Placebo

First Posted Date: 2010-12-16

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 382

Registration Number: NCT01261611

Locations: 🇷🇺
Samara Regional Clinical Hospital, Samara, Russian Federation
🇵🇱
Gabinet Lekarski, Lodz, Poland
🇷🇺
Research Medical Complex "Vashe Zdorovie", Kazan, Russian Federation

and more 45 locations

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Triptorelin Pamoate (Pamorelin® LA 11.25 mg)

First Posted Date: 2010-12-09

Last Posted Date: 2019-02-08

Lead Sponsor: Ipsen

Target Recruit Count: 109

Registration Number: NCT01257425

Locations: 🇩🇪
Urologische Klinik, Neunkirchen, Germany
🇩🇪
Praxis für Urologie, Wuppertal, Germany
🇩🇪
Kreiskrankenhaus, Abteilung Urologie, Bad Bergzabern, Germany

and more 1 locations

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Phase 2

Terminated

Conditions: Endometrial Cancer

Interventions: Drug: BN83495

First Posted Date: 2010-12-01

Last Posted Date: 2019-01-14

Lead Sponsor: Ipsen

Target Recruit Count: 6

Registration Number: NCT01251354

Locations: 🇺🇸
Dept of Obstetrics and Gynecology, Medical College of Georgia, Augusta, Georgia, United States
🇨🇦
Dept of Obstetrics and Gynecology, Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada

and more 6 locations

Dysport® Adult Lower Limb Spasticity Follow-on Study

Phase 3

Completed

Conditions: Spasticity Post-Traumatic Brain Injury
Post-stroke Spasticity

Interventions: Biological: Botulinum toxin type A

First Posted Date: 2010-12-01

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 352

Registration Number: NCT01251367

Locations: 🇵🇱
Krakowska Akademia Neurologii Sp. z o.o., Krakow, Poland
🇸🇰
Derer's Hospital, Bratislava, Slovakia
🇸🇰
Univerzitna nemocnica Bratislava, Bratislava, Slovakia

and more 46 locations

Dysport® Pediatric Lower Limb Spasticity Follow-on Study

Phase 3

Completed

Conditions: Children
Muscle Spasticity
Cerebral Palsy

Interventions: Biological: Botulinum toxin type A

First Posted Date: 2010-12-01

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 216

Registration Number: NCT01251380

Locations: 🇺🇸
The Children's Hospital, Aurora, Colorado, United States
🇺🇸
Gillette Children's Speciality Healthcare, Saint Paul, Minnesota, United States
🇹🇷
Ghulane Military Medical Academy and School of Medicine, Ankara, Turkey

and more 24 locations

Dysport® Adult Lower Limb Spasticity Study

Phase 3

Completed

Conditions: Leg Spasticity

Interventions: Biological: Botulinum toxin type A
Drug: Placebo

First Posted Date: 2010-11-29

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 388

Registration Number: NCT01249404

Locations: 🇺🇸
The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
🇺🇸
University of Texas - Houston, Houston, Texas, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

and more 58 locations

Dysport® Pediatric Lower Limb Spasticity Study

Phase 3

Completed

Conditions: Muscle Spasticity
Children
Cerebral Palsy

Interventions: Biological: Botulinum toxin type A
Drug: Placebo

First Posted Date: 2010-11-29

Last Posted Date: 2022-09-28

Lead Sponsor: Ipsen

Target Recruit Count: 241

Registration Number: NCT01249417

Locations: 🇺🇸
Texas Scottish Rite - Hospital for Children, Dallas, Texas, United States
🇺🇸
Children's Hospital of Michigan, Detroit, Michigan, United States
🇲🇽
Centro de Rehabilitacion Integral de Queretaro (CRIQ), Queretaro, Mexico

and more 26 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy